C12N 2795/10363
By chemical treatment
Official title: by chemical treatment
C12N2795/10363 (By chemical treatment) appears on 6 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 4
- Assignees
- 4
- Inventors
- 11
- Latest grant
- 24 Mar 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods for treating spinal muscular atrophy24 Mar 2015US 8,986,935 B2PTC Therapeutics, Inc.
- Screening assays for compounds that modulate programmed ribosomal frameshifting13 Jan 2015US 8,932,818 B2PTC Therapeutics, Inc.
- Method of inactivation of viral and bacterial blood contaminants13 Feb 2001US 6,187,572 B1Baxter International Inc.
- Method of inactivation of viral and bacterial blood contaminants24 Dec 1996US 5,587,490 ACredit Managers Association of California
- Method of inactivation of viral and bacterial blood contaminants23 May 1995US 5,418,130 ACryopharm Corporation
- Methods for treating viral infections3 Dec 2015US 2015/0344877 A1PTC Therapeutics, Inc.
- Methods for treating spinal muscular atrophy8 Oct 2015US 2015/0283115 A1PTC Therapeutics, Inc.
- Methods for treating viral infections1 Sep 2011US 2011/0213005 A1PTC Therapeutics, Inc.
- Methods for treating spinal muscular atrophy14 Jul 2011US 2011/0172284 A1PTC Therapeutics, Inc.
Most cited
By later US patents
- Method of inactivation of viral and bacterial blood contaminants114US 5,418,130 ACryopharm Corporation · 1995
- Method of inactivation of viral and bacterial blood contaminants64US 6,187,572 B1Baxter International Inc. · 2001
- Method of inactivation of viral blood contaminants using acridine deriatives55US 5,342,752 ACryopharm Corporation · 1994
- Method of inactivation of viral and bacterial blood contaminants54US 5,587,490 ACredit Managers Association of California · 1996